China · Delayed Price · Currency is CNY Newland Pharmaceutical Statistics
Total Valuation
SHE:301277 has a market cap or net worth of CNY 4.11 billion. The enterprise value is 3.49 billion.
| Market Cap | 4.11B |
| Enterprise Value | 3.49B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Apr 30, 2026 |
Share Statistics
SHE:301277 has 392.08 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 392.08M |
| Shares Outstanding | 392.08M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 63.57% |
| Owned by Institutions (%) | 1.31% |
| Float | 99.62M |
Valuation Ratios
The trailing PE ratio is 39.38.
| PE Ratio | 39.38 |
| Forward PE | n/a |
| PS Ratio | 5.78 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 99.83 |
| P/OCF Ratio | 45.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.48, with an EV/FCF ratio of 84.87.
| EV / Earnings | 33.56 |
| EV / Sales | 4.91 |
| EV / EBITDA | 21.48 |
| EV / EBIT | 34.98 |
| EV / FCF | 84.87 |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.52 |
| Quick Ratio | 5.93 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.10 |
| Interest Coverage | 630.48 |
Financial Efficiency
Return on equity (ROE) is 6.72% and return on invested capital (ROIC) is 9.56%.
| Return on Equity (ROE) | 6.72% |
| Return on Assets (ROA) | 3.54% |
| Return on Invested Capital (ROIC) | 9.56% |
| Return on Capital Employed (ROCE) | 6.26% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | 724,308 |
| Profits Per Employee | 105,994 |
| Employee Count | 981 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 6.50 |
Taxes
In the past 12 months, SHE:301277 has paid 13.56 million in taxes.
| Income Tax | 13.56M |
| Effective Tax Rate | 11.71% |
Stock Price Statistics
The stock price has decreased by -17.62% in the last 52 weeks. The beta is 0.18, so SHE:301277's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -17.62% |
| 50-Day Moving Average | 10.28 |
| 200-Day Moving Average | 11.12 |
| Relative Strength Index (RSI) | 55.82 |
| Average Volume (20 Days) | 2,833,239 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301277 had revenue of CNY 710.55 million and earned 103.98 million in profits. Earnings per share was 0.27.
| Revenue | 710.55M |
| Gross Profit | 202.94M |
| Operating Income | 99.76M |
| Pretax Income | 115.77M |
| Net Income | 103.98M |
| EBITDA | 159.86M |
| EBIT | 99.76M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 618.62 million in cash and 4.22 million in debt, with a net cash position of 614.40 million or 1.57 per share.
| Cash & Cash Equivalents | 618.62M |
| Total Debt | 4.22M |
| Net Cash | 614.40M |
| Net Cash Per Share | 1.57 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 3.91 |
| Working Capital | 885.55M |
Cash Flow
In the last 12 months, operating cash flow was 90.69 million and capital expenditures -49.57 million, giving a free cash flow of 41.12 million.
| Operating Cash Flow | 90.69M |
| Capital Expenditures | -49.57M |
| Depreciation & Amortization | 60.11M |
| Net Borrowing | 133,800 |
| Free Cash Flow | 41.12M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 28.56%, with operating and profit margins of 14.04% and 14.63%.
| Gross Margin | 28.56% |
| Operating Margin | 14.04% |
| Pretax Margin | 16.29% |
| Profit Margin | 14.63% |
| EBITDA Margin | 22.50% |
| EBIT Margin | 14.04% |
| FCF Margin | 5.79% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.91%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.91% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 75.41% |
| FCF Payout Ratio | 190.71% |
| Buyback Yield | 0.13% |
| Shareholder Yield | 2.04% |
| Earnings Yield | 2.53% |
| FCF Yield | 1.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Apr 16, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:301277 has an Altman Z-Score of 15.02 and a Piotroski F-Score of 5.
| Altman Z-Score | 15.02 |
| Piotroski F-Score | 5 |